{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T03:36:04Z","timestamp":1758080164753,"version":"3.44.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,16]]},"DOI":"10.7759\/cureus.92467","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:11:47Z","timestamp":1758042707000},"source":"Crossref","is-referenced-by-count":0,"title":["Upadacitinib in a Refractory Case of Alpha-1 Antitrypsin Deficiency-Related Panniculitis"],"prefix":"10.7759","author":[{"given":"Majda","family":"Chaoui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"De Greef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliane","family":"Marot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Baeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/00003465-200511000-00001","article-title":"Alpha1-antitrypsin deficiency: incidence and implications","volume":"24","author":"Richmond RJ","year":"2005","unstructured":"Richmond RJ, Zellner KM. Alpha1-antitrypsin deficiency: incidence and implications. Dimens Crit Care Nurs. 2005, 24:255-60. 10.1097\/00003465-200511000-00001","journal-title":"Dimens Crit Care Nurs"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.36141\/svdld.v37i4.9877","article-title":"A rare mutation on alpha-1 antitrypsin deficit and lung fibrosis: case report","volume":"37","author":"Afonso M","year":"2020","unstructured":"Afonso M, Silva C, Pinho I, Vale A, Fernandes A. A rare mutation on alpha-1 antitrypsin deficit and lung fibrosis: case report. Sarcoidosis Vasc Diffuse Lung Dis. 2020, 37:2020019. 10.36141\/svdld.v37i4.9877","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14309","article-title":"Neutrophilic panniculitis associated with alpha-1-antitrypsin deficiency: an update","volume":"174","author":"Blanco I","year":"2016","unstructured":"Blanco I, Lipsker D, Lara B, Janciauskiene S. Neutrophilic panniculitis associated with alpha-1-antitrypsin deficiency: an update. Br J Dermatol. 2016, 174:753-62. 10.1111\/bjd.14309","journal-title":"Br J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.12.053","article-title":"Alpha-1-antitrypsin associated panniculitis: the MS variant","volume":"51","author":"Geraminejad P","year":"2004","unstructured":"Geraminejad P, DeBloom JR 2nd, Walling HW, Sontheimer RD, VanBeek M. Alpha-1-antitrypsin associated panniculitis: the MS variant. J Am Acad Dermatol. 2004, 51:645-55. 10.1016\/j.jaad.2003.12.053","journal-title":"J Am Acad Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/CPM.0b013e3181672239","article-title":"Panniculitis in alpha-1 antitrypsin deficiency: a review","volume":"15","author":"Stoller JK","year":"2008","unstructured":"Stoller JK, Piliang M. Panniculitis in alpha-1 antitrypsin deficiency: a review. Clin Pulm Med. 2008, 15:113-7. 10.1097\/CPM.0b013e3181672239","journal-title":"Clin Pulm Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.01.074","article-title":"Alpha-1 antitrypsin deficiency-associated panniculitis","volume":"87","author":"Franciosi AN","year":"2022","unstructured":"Franciosi AN, Ralph J, O'Farrell NJ, et al.. Alpha-1 antitrypsin deficiency-associated panniculitis. J Am Acad Dermatol. 2022, 87:825-32. 10.1016\/j.jaad.2021.01.074","journal-title":"J Am Acad Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000526156","article-title":"Acute disseminated panniculitis associated with alpha-1 antitrypsin deficiency","volume":"14","author":"Murinello AG","year":"2022","unstructured":"Murinello AG, S\u00e1 Dam\u00e1sio H, Guedes P, de Figueiredo AM, Santos A, Serrano A. Acute disseminated panniculitis associated with alpha-1 antitrypsin deficiency. Case Rep Dermatol. 2022, 14:283-90. 10.1159\/000526156","journal-title":"Case Rep Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201901-0010OC","article-title":"The biological effects of double-dose alpha-1 antitrypsin augmentation therapy. A pilot clinical trial","volume":"200","author":"Campos MA","year":"2019","unstructured":"Campos MA, Geraghty P, Holt G, et al.. The biological effects of double-dose alpha-1 antitrypsin augmentation therapy. A pilot clinical trial. Am J Respir Crit Care Med. 2019, 200:318-26. 10.1164\/rccm.201901-0010OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2023.05.010","article-title":"Successful treatment of rheumatoid neutrophilic panniculitis with tofacitinib","volume":"99","author":"Almeida Junior HL","year":"2024","unstructured":"Almeida Junior HL, Furtado VD, Issaacson VS, Boff AL. Successful treatment of rheumatoid neutrophilic panniculitis with tofacitinib. An Bras Dermatol. 2024, 99:644-7. 10.1016\/j.abd.2023.05.010","journal-title":"An Bras Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.17354","article-title":"A double-blind pilot study of oral baricitinib in adult patients with lupus erythematosus panniculitis","volume":"51","author":"Chen J","year":"2024","unstructured":"Chen J, Luo Y, Duan Y, et al.. A double-blind pilot study of oral baricitinib in adult patients with lupus erythematosus panniculitis. J Dermatol. 2024, 51:1434-40. 10.1111\/1346-8138.17354","journal-title":"J Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.21252","article-title":"Improvement of cutaneous inflammation and panniculitis in patients with dermatomyositis by the Janus kinase inhibitor baricitinib","volume":"187","author":"Fischer K","year":"2022","unstructured":"Fischer K, Aringer M, Steininger J, Heil J, Beissert S, Abraham S, G\u00fcnther C. Improvement of cutaneous inflammation and panniculitis in patients with dermatomyositis by the Janus kinase inhibitor baricitinib. Br J Dermatol. 2022, 187:432-5. 10.1111\/bjd.21252","journal-title":"Br J Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-025-03816-9","article-title":"Panniculitis: a narrative review","volume":"317","author":"Maniam GB","year":"2025","unstructured":"Maniam GB, Limmer EE, Gibson LE, Tolkachjov SN, Alavi A. Panniculitis: a narrative review. Arch Dermatol Res. 2025, 317:373. 10.1007\/s00403-025-03816-9","journal-title":"Arch Dermatol Res"},{"key":"ref13","article-title":"Alpha-1-antitrypsin deficiency-associated panniculitis: a case report","volume":"20","author":"Laureano A","year":"2014","unstructured":"Laureano A, Carvalho R, Chaveiro A, Cardoso J. Alpha-1-antitrypsin deficiency-associated panniculitis: a case report. Dermatol Online J. 2014, 20:21245.","journal-title":"Dermatol Online J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-024-01117-z","article-title":"Successful treatment of disseminated granuloma annulare with upadacitinib","volume":"14","author":"De Greef A","year":"2024","unstructured":"De Greef A, Benjelloun G, Harkemanne E, Baeck M. Successful treatment of disseminated granuloma annulare with upadacitinib. Dermatol Ther (Heidelb). 2024, 14:813-7. 10.1007\/s13555-024-01117-z","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2024.2378","article-title":"Upadacitinib for treatment of granulomatous cheilitis","volume":"160","author":"De Greef A","year":"2024","unstructured":"De Greef A, Peeters C, Dewit O, de Montjoye L, Baeck M. Upadacitinib for treatment of granulomatous cheilitis. JAMA Dermatol. 2024, 160:1001-3. 10.1001\/jamadermatol.2024.2378","journal-title":"JAMA Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14712","article-title":"Successful use of baricitinib in the treatment of refractory rheumatoid arthritis-associated Sweet syndrome","volume":"46","author":"Nousari Y","year":"2021","unstructured":"Nousari Y, Wu BC, Valenzuela G. Successful use of baricitinib in the treatment of refractory rheumatoid arthritis-associated Sweet syndrome. Clin Exp Dermatol. 2021, 46:1330-2. 10.1111\/ced.14712","journal-title":"Clin Exp Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-021-05860-w","article-title":"Interferon-\u03b3 induces interleukin-6 production by neutrophils via the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway","volume":"14","author":"Yoshida S","year":"2021","unstructured":"Yoshida S, Yamada S, Yokose K, et al.. Interferon-\u03b3 induces interleukin-6 production by neutrophils via the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway. BMC Res Notes. 2021, 14:447. 10.1186\/s13104-021-05860-w","journal-title":"BMC Res Notes"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/389207-upadacitinib-in-a-refractory-case-of-alpha-1-antitrypsin-deficiency-related-panniculitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:11:48Z","timestamp":1758042708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/389207-upadacitinib-in-a-refractory-case-of-alpha-1-antitrypsin-deficiency-related-panniculitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.92467","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,16]]}}}